Thomas Nalpathamkalam

Mr. Thomas Nalpathamkalam

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GGGraham Gilchrist
Graham Gilchrist
ATAllison Tscherner
Allison Tscherner
TNThomas Nalpathamkalam
Thomas Nalpathamkalam
DMDaniele Merico
Daniele Merico
JLJonathan LaMarre
Jonathan LaMarre
Successful fertilization and subsequent embryo development rely on complex molecular processes starting with the development of oocyte competence through maturation. MicroRNAs (miRNAs) are small non-coding RNA molecules that function as gene regulators in many biological systems, including the oocyte and embryo. In order to further explore the roles of miRNAs in oocyte maturation, we employed small RNA sequencing as a screening tool to identify and characterize miRNA populations present in pools of bovine germinal vesicle (GV) oocytes, metaphase II (MII) oocytes, and presumptive zygotes (PZ). Each stage contained a defined miRNA population, some of which showed stable expression while others showed progressive changes between stages that were subsequently confirmed by quantitative reverse transcription polymerase chain reaction (RT-PCR). Bta-miR-155, bta-miR-222, bta-miR-21, bta-let-7d, bta-let-7i, and bta-miR-190a were among the statistically significant differentially expressed miRNAs (p < 0.05). To determine whether changes in specific primary miRNA (pri-miRNA) transcripts were responsible for the observed miRNA changes, we evaluated pri-miR-155, -222 and let-7d expression. Pri-miR-155 and -222 were not detected in GV oocytes but pri-miR-155 was present in MII oocytes, indicating transcription during maturation. In contrast, levels of pri-let-7d decreased during maturation, suggesting that the observed increase in let-7d expression was likely due to processing of the primary transcript. This study demonstrates that both dynamic and stable populations of miRNAs are present in bovine oocytes and zygotes and extend previous studies supporting the importance of the small RNA landscape in the maturing bovine oocyte and early embryo.

30 July 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
MRMiriam S. Reuter
Miriam S. Reuter
RCRajiv R. Chaturvedi
Rajiv R. Chaturvedi
RJRebekah K. Jobling
Rebekah K. Jobling
GPGiovanna Pellecchia
Giovanna Pellecchia
OHOmar Hamdan
Omar Hamdan
ABAnne S. Bassett
Anne S. Bassett
Background: Tetralogy of Fallot (TOF)—the most common cyanotic heart defect in newborns—has evidence of multiple genetic contributing factors. Identifying variants that are clinically relevant is essential to understand patient-specific disease susceptibility and outcomes and could contribute to delineating pathomechanisms. Methods: Using a clinically driven strategy, we reanalyzed exome sequencing data from 811 probands with TOF, to identify rare loss-of-function and other likely pathogenic variants in genes associated with congenital heart disease. Results: We confirmed a major contribution of likely pathogenic variants in FLT4 (VEGFR3 [vascular endothelial growth factor receptor 3]; n=14) and NOTCH1 (n=10) and identified 1 to 3 variants in each of 21 other genes, including ATRX , DLL4 , EP300 , GATA6 , JAG1 , NF1 , PIK3CA , RAF1 , RASA1 , SMAD2 , and TBX1 . In addition, multiple loss-of-function variants provided support for 3 emerging congenital heart disease/TOF candidate genes: KDR (n=4), IQGAP1 (n=3), and GDF1 (n=8). In total, these variants were identified in 63 probands (7.8%). Using the 26 composite genes in a STRING protein interaction enrichment analysis revealed a biologically relevant network ( P =3.3×10 −16 ), with VEGFR2 (vascular endothelial growth factor receptor 2; KDR ) and NOTCH1 (neurogenic locus notch homolog protein 1) representing central nodes. Variants associated with arrhythmias/sudden death and heart failure indicated factors that could influence long-term outcomes. Conclusions: The results are relevant to precision medicine for TOF. They suggest considerable clinical yield from genome-wide sequencing, with further evidence for KDR (VEGFR2) as a congenital heart disease/TOF gene and for VEGF (vascular endothelial growth factor) and Notch signaling as mechanisms in human disease. Harnessing the genetic heterogeneity of single gene defects could inform etiopathogenesis and help prioritize novel candidate genes for TOF.

17 June 2014 in BMC Proceedings
Verified
Journal Article
Open access
PDF file
TNThomas Nalpathamkalam
Thomas Nalpathamkalam
ADAndriy Derkach
Andriy Derkach
APAndrew Paterson
Andrew Paterson
DMDaniele Merico
Daniele Merico
Grouping variants based on gene mapping can augment the power of rare variant association tests. Weighting or sorting variants based on their expected functional impact can provide additional benefit. We defined groups of prioritized variants based on systematic annotation of Genetic Analysis Workshop 18 (GAW18) single-nucleotide variants; we focused on variants detected by whole genome sequencing, specifically on the high-quality subset presented in the genotype files. First, we divided variants between coding and noncoding. Coding variants are fewer than 1% of the total and are more likely to have a biological effect than noncoding variants. Coding variants were further stratified into protein changing and protein damaging groups based on the effect on protein amino acid sequence. In particular, missense variants predicted to be damaging, splice-site alterations, and stop gains were assigned to the protein damaging category. Impact of noncoding variants is more difficult to predict. We decided to rely uniquely on conservation: we combined (a) the mammalian phastCons Conserved Element and (b) the PhyloP score, which identify conserved intervals and the single-nucleotide position, respectively. This reduced the noncoding variants to a number comparable to coding variants. Finally, using gene structure definition from the widely used RefSeq database, we mapped variants to genes to support association tests that require collapsing rare variants to genes. Companion GAW18 papers used these variant priority groups and gene mapping; one of these paper specifically found evidence of stronger association signal for protein damaging variants.

31 August 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
SCSharon Clouthier
Sharon Clouthier
MTMarek Tomczyk
Marek Tomczyk
TSTamara Schroeder
Tamara Schroeder
CKCheryl Klassen
Cheryl Klassen
ADAndré Dufresne
André Dufresne
BTBhooma Thiruvahindrapuram
Bhooma Thiruvahindrapuram
Herpesvirus infections of sturgeon pose a potential threat to sturgeon culture efforts worldwide. A new epitheliotropic herpesvirus named Acipenser herpesvirus 3 (AciHV-3) was detected in hatchery-reared Lake Sturgeon Acipenser fulvescens displaying skin lesions in central Canada. The growths were discovered in the fall, reached average prevalence levels of 0.2–40% and eventually regressed. No unusual mortality was observed. The cellular changes within the lesions included epithelial hyperplasia and were reminiscent of other herpesvirus infections. The virus was not evident in lesions examined by electron microscopy. Skin tissue homogenates from symptomatic sturgeon produced atypical cytopathic effects on a primary Lake Sturgeon cell line, and next-generation sequence analysis of the DNA samples revealed the presence of an alloherpesvirus. A new genotyping PCR assay targeting the major capsid protein sequence detected AciHV-3 in symptomatic Lake Sturgeon as well as other apparently healthy sturgeon species. Bayesian inference of phylogeny reconstructed with a concatenation of five alloherpesvirus core proteins revealed a new Alloherpesviridae lineage isomorphic with a new genus. The presence of AciHV-3 homologs in cell lines and sturgeon sequence datasets, low sequence divergence among these homologs and branching patterns within the genotyping phylogeny provide preliminary evidence of an endogenous virus lifestyle established in an ancestral sturgeon.

21 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
WEWorrawat Engchuan
Worrawat Engchuan
KHKara Han
Kara Han
RFRayssa Mmw Feitosa
Rayssa Mmw Feitosa
NSNelson Bautista Salazar
Nelson Bautista Salazar
David Joseph MagerDavid Joseph Mager
David Joseph Mager
JVJacob Vorstman
Jacob Vorstman
Compound heterozygous events involving a chromosome deletion and on the remaining allele a functional DNA sequence-level variant can underpin a range of medical conditions. Most large-scale genetic studies do not include a systematic analysis of such compound heterozygous deletion (DelCH) events. We developed three frameworks: i) traditional burden analysis; ii) deletion-matched burden analysis; and iii) transmission disequilibrium test (TDT), to examine the possible contribution of DelCH to clinical presentations, and report results of their implementation in 9,766 families of autistic individuals. Across the three strategies, we observed enrichment of rare DelCH events in autistic individuals at a nominal significance level for individual tests. Collectively, six genes; CFHR4 , HSDL1 , MYO15A , NEFH , and three olfactory receptor genes; OR1A2 , OR4P2 , were affected by DelCH events in at least two unrelated autistic individuals (and not in unaffected family members), while the reverse analyses identified no genes (p<2.2 x 10 -16 ). Gene set enrichment analysis of the extended network of candidate genes showing a remarkable convergence to processes related to neurogenesis. Our findings suggest a modest role for DelCH events in ASD. The strategies described here are available via a GitHub repository, allowing the research community to examine the role of DelCH in other genome sequencing cohorts.

13 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
BHBushra Haque
Bushra Haque
DCDavid Cheerie
David Cheerie
APAmy Pan
Amy Pan
MCMeredith Curtis
Meredith Curtis
TNThomas Nalpathamkalam
Thomas Nalpathamkalam
GCGregory Costain
Gregory Costain
Background Innovative and easy-to-implement strategies are needed to improve the pathogenicity assessment of rare germline missense variants. Somatic cancer driver mutations identified through large-scale tumor sequencing studies often impact genes that are also associated with rare Mendelian disorders. The use of cancer mutation data to aid in the interpretation of germline missense variants, regardless of whether the gene is associated with a hereditary cancer predisposition syndrome or a non-cancer-related developmental disorder, has not been systematically assessed. Methods We extracted putative cancer driver missense mutations from the Cancer Hotspots database and annotated them as germline variants, including presence/absence and classification in ClinVar. We trained two supervised learning models (logistic regression and random forest) to predict variant classifications of germline missense variants in ClinVar using Cancer Hotspot data (training dataset). The performance of each model was evaluated with an independent test dataset generated in part from searching public and private genome-wide sequencing datasets from ∼1.5 million individuals. Results Of the 2,447 cancer mutations, 691 corresponding germline variants had been previously classified in ClinVar: 426 (61.6%) as likely pathogenic/pathogenic, 261 (37.8%) as uncertain significance, and 4 (0.6%) as likely benign/benign. The odds ratio for a likely pathogenic/pathogenic classification in ClinVar was 28.3 (95% confidence interval: 24.2-33.1, p < 0.001), compared with all other germline missense variants in the same 216 genes. Both supervised learning models showed high correlation with pathogenicity assessments in the training dataset. There was high area under precision-recall curve values of 0.847 and 0.829 for logistic regression and random forest models, respectively, when applied to the test dataset. Conclusion Cancer mutation data can be leveraged to improve the interpretation of germline missense variation potentially causing rare Mendelian disorders.